Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children.
about
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipientsPre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipientsAntiviral medications for preventing cytomegalovirus disease in solid organ transplant recipientsPre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipientsPosttransplant lymphoproliferative disorders following liver transplantation: Where are we now?New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipientsPrevention of cytomegalovirus disease in recipients of solid-organ transplants.Prevention of infections in solid organ transplant recipients.Prevention and treatment of cytomegalovirus infection in organ transplant recipients.Viral infections and pediatric liver transplantation.Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease.Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease.Management of opportunistic infections in solid-organ transplantation.Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatmentCytomegalovirus-associated chorioretinitis after liver transplantation: case report and review of the literature.Cytomegalovirus risk, prevention, and management in pediatric solid organ transplantation.Recent developments in the prevention and treatment of Epstein-Barr virus-associated lymphoproliferative diseases.Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection.The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review.Effect of early EBV and/or CMV viremia on graft function and acute cellular rejection in pediatric liver transplantation.Preventing CMV and EBV in children undergoing organ transplantation: Retrospective studies can only teach us so much.
P2860
Q24200697-7247C91F-48AA-4A9C-AB59-0548DE9A9890Q24200991-1E217B91-AD0B-4671-8A79-CF3FB201ECB8Q24243124-5AC995C7-7427-4ED4-8AAD-EE9AA2122B3CQ24244606-124D4EAC-EC5A-4D17-8FB5-438BC4261270Q26780262-F4ADF0E6-D5B7-4064-9B49-F6977B606763Q33812425-4B561119-470D-4892-B46D-C14E32B97CEBQ34142019-2C8B463B-EAAC-4C4F-847B-71C187830FD8Q34294796-D3B7AE65-7A1C-4A2B-92F6-E68931D8BA33Q34294851-D6FDB717-E955-4CFE-8B41-8FC92F7040A2Q34572726-5A9D5369-EE49-4EEB-8165-8BECB50C4D8AQ34769887-B5DAC307-25C3-412C-8D16-8873FCD1AE4DQ34946254-6361B428-4105-44E1-94F3-1B0ECF6BAF10Q35841369-46F788C1-C659-4EE7-A046-7FA871DB76E8Q36170494-1D1F3773-2012-4461-9DB6-23CD4BB5516BQ37034498-511275FD-93E7-4390-B617-E187714B8333Q37825594-D36DA0AD-BAE7-4CA0-9350-40F376C60780Q37906623-4331311A-F60E-41CF-9BF3-4A20E07ABEBDQ38271850-06A858B3-FA59-41D4-8335-F1706428F16FQ38933152-36510E0B-1E15-40B5-8DD3-15AFFEF2D5CDQ45279415-620F9194-7963-436C-8331-9E587C307E66Q47912149-D3D35AAF-520E-47DC-B1E4-3F3B629FA9DE
P2860
Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Comparison of intravenous ganc ...... r transplantation in children.
@en
Comparison of intravenous ganc ...... r transplantation in children.
@nl
type
label
Comparison of intravenous ganc ...... r transplantation in children.
@en
Comparison of intravenous ganc ...... r transplantation in children.
@nl
prefLabel
Comparison of intravenous ganc ...... r transplantation in children.
@en
Comparison of intravenous ganc ...... r transplantation in children.
@nl
P2093
P921
P356
P1476
Comparison of intravenous ganc ...... r transplantation in children.
@en
P2093
P304
P356
10.1086/516139
P407
P577
1997-12-01T00:00:00Z